Page 71 of The Gene


  erythropoietin, 308

  ES cells. See embryonic stem cells

  Escherichia coli (E. coli), 173, 174, 175, 180, 207, 209–10, 211, 212, 228–29

  Essay on the Principle of Population, The (Malthus), 37, 38

  estrogen

  sexual reassignment using, 363, 365

  in women with Swyer syndrome, 363

  ethical issues. See also moral issues

  death in gene-therapy trial in OTC deficiency and, 432–33, 434–35, 465

  ES cells and genetic changes and, 473, 477

  fetal testing for homosexuality and, 377

  gene cloning and, 233

  gene-therapy trials in children and, 430, 434, 435, 465

  human genome engineering and, 478

  patenting recombinant DNA techniques and, 237

  preimplantation genetic diagnosis (PGD) and, 456–57, 464

  propagating genetic hybrids in bacterial cells and, 209

  recombinant DNA technology and, 233

  scientists’ proposal for a moratorium on use of genomic engineering due to, 477

  sexual selection for male children and, 456–57

  transgenic animals in gene research and, 421

  ethnic cleansing, 138. See also genetic cleansing; racial cleansing

  eugenic camps, 120, 227. See also colonies

  eugenics, 64–77. See also neo-eugenics (newgenetics)

  American programs for, 77, 344

  critics of, 73–74

  early public support for, 73, 74, 75–77

  equality in social conditions needed for, 116–17

  fear of racial degeneration and, 75

  fittest babies contests and, 85

  Galton’s coining of word, 65, 72, 502

  Galton’s promotion of, 64–65, 72–75, 110, 116, 120, 159, 273, 343, 502

  gene therapies and, 464

  Muller’s mutation research and opinions on, 116–17, 274

  Nazi racial extermination programs justified by, 124–25, 138

  Nazi sterilization programs based on, 120, 121–22, 123, 124, 125

  neo-eugenics (newgenetics) differentiated from, 272–73, 275

  racial hygiene theory and, 76–77, 120–21

  radiation-induced genetic changes for, 116

  renunciation of, after Nazi’s use of, 138, 259

  selective breeding proposals for, 73, 74, 75

  sexual selection for male children and, 456–57

  sterilization proposals for, 74, 75–76

  Eugenics Court (Germany), 121

  Eugenics Record Office, 77, 85, 116, 138

  Eugenics Review (journal), 76

  Eumenides (Aeschylus), 21

  European Early Modern Human (EEMH), 333

  euthanasia program for genetic defectives, in Nazi Germany, 13, 122–24

  Evans, Martin, 419

  evolution

  Agassiz’s theory of multiple origins and theory of, 331

  cancer as a genetic disease related to, 297

  Darwin’s gemmule theory of, 43–44, 57, 66, 113, 395–96

  early modern humans and, 332–33

  genetic memory as challenge to, 395

  genetics reconciled with, 102, 104–08

  genomic information for, 333n

  information theory on impact of mutations on, 413

  natural selection and, 40–41, 104–05, 331

  Neanderthals’ place in, 332–33

  phenotype as interactions between heredity, chance, environment, variation and, 107–08

  theory of heredity needed with, 57, 65, 66

  Wallace’s general theory of, 39

  exome sequencing, 443

  exons, 219, 295, 323, 443

  “Experiments in Plant Hybridization” (Mendel), 46, 60

  extermination camps, in Nazi Germany, 124–25, 129–30, 137–38, 226

  factor VIII gene, in humans, 197, 247–48

  factor VIII therapy, 246–47, 249

  factor IX gene therapy, 466

  Falkow, Stan, 212, 213

  familial schizophrenia, 8, 442, 444–45, 446n, 461

  fantasies

  human genome encoded with, 483

  in schizophrenia, 4

  sexual behavior related to, 365, 366

  Fantastic Four (comic-book series), 266

  fate map for individual genomes, 191, 488–89

  fear extinction, 492n

  fears, in schizophrenia, 2, 4, 5

  FBI, 117

  FDA, 249, 434, 435

  feebleminded

  eugenics and sterilization of, 77, 78–79, 80, 81, 116, 120

  Nazi racial cleansing program for, 124

  Feldburg, Wilhelm, 131

  Feldman, Martin, 336, 338, 342

  Fermat, Pierre de, 56–57

  fetal cell tests, 267

  films

  eugenics education using, 85

  Nazi propaganda using, 121

  Fisher, Ronald, 103–04, 399

  fittest babies contests, 85

  fittest concept. See survival of the fittest

  5HTTLRP gene, in humans, 459–60

  fly genetics. See fruit flies

  “For Whom the Bell Curves” (Patterson), 348

  fossils

  Darwin’s collection of, 32, 33–34, 221n

  Herschel’s origin theory and, 30

  human origin and migration theory and, 336

  Foucault, Michel, 462

  Franklin, Rosalind

  background and training of, 143–44

  criticism of Watson and Crick’s double-helix DNA model by, 151–52

  imaging research on DNA structure by, 13, 144–45, 149–50, 153, 153n, 155, 158, 159, 314, 502

  Watson’s reaction to research of, 149–50, 150n, 154

  fraternal twins. See twins; twin studies

  Freud, Sigmund, 442

  Friedman, Richard, 491, 492n

  frogs

  gene insertion experiments with, 229, 231, 236

  nuclear transfer experiments with, 396–99, 402, 404

  Yamanaka’s cell-fate reversal experiment in, 404–05

  fruit flies

  cell-fate determination in embryonic development studies using, 186–91, 195

  chromosome research using, 93–94, 95, 96–97

  comparisons between human and worm genes with, 316–17

  environmental triggers for gene actualization in, 263–64

  gene action research using, 162

  genetic variant experiments using, 105–08, 110

  genome sequencing of, 303, 315–17

  as model system for research, 259

  number of genes in, 316

  Science publication of genome of, 316–17

  Fruit Fly Genome Project, 303

  “Funes the Memorious” (Borges), 403

  Future of Genomic Medicine conference (2013), Scripps Institute, La Jolla, California, 450

  Galápagos Islands, 33, 38, 41

  Galen, 356

  Galton, Francis, 62, 64–70

  Ancestral Law of Heredity of, 68–69, 72

  background and training of, 65

  Bateson’s criticism of, 69, 72

  Darwin on work of, 68

  Darwin’s research studied by, 65, 66

  eugenics promoted by, 64–65, 72–75, 110, 116, 120, 159, 273, 343, 502

  nature versus nurture research of, 67, 128

  sterilization (negative eugenics) and, 76

  twin studies used by, 128, 298

  units of information in inheritance and, 68–70, 74, 103

  variation measurements of, 66–68, 70

  Gamow, George, 164

  Gardner, Howard, 345

  Garrod, Archibald, 260–61

  gastric cancer, 405

  Gaucher’s disease, 269, 291

  Gelsinger, Jesse

  impact of death of, 434–35, 465

  OTC deficiency gene-therapy trial and, 431–34, 464, 465, 466, 503

  OTC deficiency variant i
n, 429, 430

  Gelsinger, Paul, 431, 432, 433–34, 465

  gemmule theory of heredity

  Darwin’s statement of, 43–44

  experimental proof against, 57, 66, 113

  genetic memory related to, 395–96

  GenBank, 320

  gender

  amniocentesis to predict, 267

  ancient Greek beliefs on, 356–57

  genes in determination of, 355–56, 366–67

  preimplantation genetic diagnosis (PGD) to predict, 456

  sexual selection for male children and, 456–57

  use of term, 356

  gender identity

  continuum of, 367

  genes in determination of, 355–56, 367–68

  sexual reassignment and, 363–67

  transgender identity and, 368

  use of term, 356

  of women with Swyer syndrome, 363

  gene activation

  epigenetic marks and, 403n, 418

  external triggers for, 107

  gene regulation using, 401

  gene-silencing and, 399–400, 401

  histone marking of molecular memory and, 401–02

  human embryogenesis and, 407

  mapmaker genes for, 189–90

  promoters for, 307n

  proteins for, 189, 196, 403n

  random chance for, 107

  selective, at different times and in different circumstances, 177

  gene cloning, 218, 220, 221, 292

  Asilomar II conference (1975) on, 233

  “Berg letter” on benefits and hazards of, 228

  Berg’s recombinant DNA research involving, 208–09

  of BRCA1 gene in breast cancer, 439

  coining of phrase, 222

  as conceptual shift, 294

  concerns about using, 227, 230, 231, 232, 233, 237

  of cystic fibrosis gene, 288–91

  of Dolly, the sheep, 397

  early research on linked genes and, 97

  of factor VIII gene, 247–48, 249

  finding disease-linked genes using, 276–77

  gene libraries for, 224

  Genentech’s use of, in medicine, 238, 241, 242, 243, 244, 251

  of hemochromatosis gene, 279

  Human Genome Project’s use of clone-by-clone assembly approach, 311, 313, 319

  impact of, 222, 224

  mapping genes to chromosomal locations using, 287, 288

  nuclear transfer experiments using, 397

  patent for, 237

  positional cloning technique in cystic fibrosis mapping, 288–91

  protein manufacture using, 250–51

  reverse transcriptase used with, 248

  scientists’ suggestions for regulating, 227, 229, 230, 232–33

  use of term, 13, 222

  gene editing

  intentionally changing human genome using, 489

  issues raised by, 476

  permanent and heritable changes on human embryonic stem cells using, 475

  scientists’ proposal for a moratorium on use of, 476–77

  gene expression

  epigenetic marks and, 403n

  gene-silencing and, 400

  genomic code controlling multiple genes for, 325

  Hongerwinter experience and reformatting of, 405–06

  incomplete penetrance and variability in, 389n

  intergenic DNA and introns for, 307, 324

  in schizophrenia, 447

  starvation-induced alterations in, 405

  virus genes in composite embryos and lack of, 418

  gene families, 324

  gene-fragment genome sequencing technique, 306–09, 308n

  gene mapping, 278–92

  chromosome jumping technique in, 289–90, 294

  as conceptual shift, 294

  in cystic fibrosis, 13, 289–90

  dissatisfaction with slow rate of change in, 294–95

  early research on linked genes and, 97

  failure of gene-by-gene approach in, for polygenic disorders, 295, 300

  families with genetic trait markers needed for, 281, 286

  in hemochromatosis, 278–79

  in Huntington’s disease, 13, 283–84, 361

  linkage analysis in, 109, 286, 378, 439, 445, 445n

  polymorphisms as signposts in, 280–81, 301

  positional cloning technique in, 288–91

  process of identifying gene in, 279–80, 286–88

  in schizophrenia, 445–46

  search for sex-determining gene on the Y chromosome using, 361

  as transformative moment in human genetics, 288, 291–92

  Genentech

  biotech research by, 251–52, 466

  factor VIII gene cloning by, 247–48

  federal guidelines and, 243

  founding of, 239, 241

  insulin synthesis by, 243–45, 243n, 251, 308

  somatostatin research of, 241–42

  Generation of Animals (Aristotle), 23

  gene recombination, 181–82, 184, 208, 227, 229, 231, 278, 360n

  genes

  as basic unit, 9–10, 485

  Bateson on power of, 63

  changes in conception of, due to genome sequencing, 314–15, 321

  crossing over of, 96, 97, 182, 208, 334–35, 502

  discontinuous nature of information on, 63, 103, 413

  DNA as master molecule of, 291

  embryonic development and, 102

  environmental influences on, 402–03

  eugenics and manipulation of, 74

  evolution reconciled with, 102, 104–08

  families of, 324

  flow of biological information with, 410

  four phases of quest to understand, 321

  identity and, 368–69

  information carried by, 101–02

  information theory on formation of, 412–13

  interplay of epigenes with, 407

  Johannsen’s coining of word, 71–72, 172, 502

  number of human, 322, 323

  as organizing principle for modern biology, 12

  origins of human beings seen in, 331–33

  patents for, 308–09

  perception of ourselves as assemblages of, 485–86

  Schrödinger on molecular structure of, 132

  shift from pathology focus to normalcy in research on, 330

  speculations about molecular identity of, 133–34

  Szostak’s experiment using micelles to generate self-replicating forms of, 411–12

  transcription of RNA copies of, 166–67, 182

  transformation of. See transformation

  translation of, 71–72, 164–65, 166–67, 314

  as units of selection in neo-eugenics (newgenetics), 273

  variation in. See variation

  Genes, Dreams and Realities (Burnet), 379

  gene sequencing, 13, 292

  as conceptual shift, 294

  dissatisfaction with slow rate of change in, 294–95

  gene diversity in cancer and, 297

  Human Genome Project for, 13

  impetus for sequencing entire human genome using, 295–97

  potentially treatable condition identified by, 453

  scale shift in, 293

  in schizophrenia, 443, 445, 447

  template of normal cancer genome needed in, 297–98

  use of term, 13

  gene-silencing, 399–400

  gene splicing, 219, 248, 323

  gene splitting, 219, 294

  gene therapy, 423–36

  ADA deficiency treatment using, 423–25, 426–28

  ban on trials of, 435, 437

  criticisms of approach to trials of, 433–34, 435–36

  delivery of genes into nonreproductive cells in, 422–26

  discovery of embryonic stem cells (ES cells) for, 418–19

  enthusiasm for using, 428

  ES cells and, 418

  factor IX in hemophilia and, 466


  first known attempt in humans, with beta-thalassemia, 424n

  gene-modified T cells used in, 425–27

  germ-line, 465, 467, 469, 474

  for hemophilia, 466–67

  inserting corrected gene directly into the body in, 430, 431–32, 434, 435, 436, 466

  new technologies introduced for, 465–66

  nonreproductive cells modified in, 464

  ornithine transcarbamylase (OTC) deficiency treatment using, 429–36

  permanently modified genomes in, 467–68

  positive eugenics and, 464

  reproductive cells modified in, 464–65, 467

  retroviral gene-delivery vector in, 423–25

  return of, after introspection following trial death in, 465

  two types of, 464–65

  virus genes inserted into composite embryos for, 418

  viruses for gene delivery in, 465–66

  genetically modified organisms (GMOs), 14n, 245, 418, 475

  genetic alteration, 116, 301, 421, 428, 437

  genetic cleansing, 85

  colonies for feeblemindedness and, 124

  heredity basis for, 129

  Nazi approach to racial cleansing based on, 121–22, 124, 138

  Ploetz’s theory of, 120

  Genetic Courts (Germany), 122

  genetic diagnosis, 437–62, 491. See also genetic screening; genetic tests of bipolar disorder, 450, 453, 461

  BRCA1 gene in breast cancer and, 438–40, 453

  conundrums in using, 453

  discovery of genetic links to diseases as impetus for development of, 437

  diseases selected for, 458

  example of two rare syndromes superposed on each other in, 451–52

  extraordinary suffering as condition for using, 458, 459, 461, 462, 464

  family and personal choices after variant identification in, 461, 462

  of fetal mutations using maternal blood, 450

  fundamental questions about uncertainty, risk, and choice and, 450

  gene management using, 457–58

  genes predictive of risk and, 447

  high-penetrance genes in, 458, 459, 461, 462, 464

  justifiable, noncoerced interventions used after, 458, 459, 461, 462, 464

  medical and moral conundrums with, 437–38

  penetrance and expressivity as factors in, 447

  power to determine “fitness” using, 461–62

  predictive determinants in, 438, 454–55

  preimplantation genetic diagnosis (PGD) used for, 456–57

  previvors and, 441, 453–54

  renaissance in use of, 437

  of schizophrenia, 442–47, 449–50, 453, 455, 492

  selective abortion after, 269, 269n, 273, 452, 458

  of a severe, progressive degenerative neuromuscular disease, 450–52, 453

  triangle of principles guiding use of, 458–59, 461–62, 464

  unpredictable nature of some genes and, 454

  genetic disorders

  combination of mutations and penetrance in, 299